I thought that Dr. Hanson’s talk was absolutely brilliant - one of the best that I have ever heard. Just wanted to point out that, as she said, the low percentage of NIH proposals that are funded is across the board - not just for ME/CFS grants. In fact, ME/CFS proposals are funded at a slightly higher rate than most right now. As she said, the only way around that is set-aside funding like the RFAs that we currently have for the Centers.
If Congress grants that funding, it is likely to be a large amount, but that is going to take time and lots of push from the community. Internally, NIH really hates set-aside funding for a particular disease - any disease. It really prefers proposals coming into a particular NIH Institute, being evaluated, and the best being funded.
Just because they hate it doesn’t mean that set-asides can’t happen. The likeliest area would be funds for new ME/CFS investigators. I would love to see that happen quickly, then push for Congress to allocate serious funding as the research community grows. They are not wrong when they emphasize building the research community.
I was also thrilled about the new Stanford Clinic. One of my concerns has been that research is being done largely on people who have spent years trying medications, which could alter what the researchers are looking at. The new clinic could both provide excellent care and be a source of new PWME who have not been extensively treated.
About the research at the conference, I had my usual opinion. 1) It is so great to see good scientists working together on this difficult problem; and 2) we sure have a long way to go.